Lineage Cell Therapeutics Receives CE Mark Approval for Renevia®

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/18/2026

1. NFLX
2. ISRG
3. SPY
4. AAPL
5. USB
6. NVDA
7. BA
8. GCTK
9. CFG
10. STT

Go back to Lineage Cell Therapeutics Receives CE Mark Approval for Renevia®
(NYSE: LCTX) Delayed: 1.16 -0.01 (0.85%)
Previous Close $1.17    52 Week High $ 
Open $1.15    52 Week Low $ 
Day High $1.21    P/E N/A 
Day Low $1.14    EPS $ 
Volume 856,248       

(NYSE: LCTX) Delayed: 1.16 -0.01 (0.85%)
Previous Close $1.17    52 Week High $ 
Open $1.15    52 Week Low $ 
Day High $1.21    P/E N/A 
Day Low $1.14    EPS $ 
Volume 856,248